)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Samsung Biologics
Samsung Biologics (207940) investor relations material
Samsung Biologics Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary15 May, 2026
Executive summary
Q1 2026 revenue reached KRW 1,257.1 billion, with operating profit of KRW 580.8 billion and net profit of KRW 469.2 billion, reflecting strong CDMO segment performance.
Achieved 26% year-over-year revenue growth and 35% higher operating profit, marking 27 consecutive quarters of YoY growth.
Major expansion included the acquisition of Human Genome Sciences, Inc., increasing total production capacity to 845,000 liters and strengthening the U.S. manufacturing base.
Completed spin-off of biosimilar business in November 2025, focusing on pure-play CDMO operations.
Secured new CMO and CDO projects, surpassing 440 cumulative CMO product approvals.
Financial highlights
Q1 2026 revenue: KRW 1,257.1B, up from KRW 999.5B in Q1 2025 (+26%).
Operating profit: KRW 580.8B, up from KRW 430B (+35%).
Net profit: KRW 469.2B, up from KRW 202B (+63.9%).
EBITDA: KRW 675B, EBITDA margin 53.7% (up 2.2 percentage points YoY).
Cash and cash equivalents at quarter-end were KRW 520.4B, up from KRW 148.9B at the end of 2025.
Outlook and guidance
On track to meet annual guidance, supported by full operation of existing plants and Plant 5 ramp-up.
Forecasted annual revenue growth of 15-20%.
Plans to expand into mRNA, ADC, and cell/gene therapy manufacturing, with new facilities completed and more planned by 2027.
Continued investment in research services and end-to-end solutions to drive future growth.
Rockville facility scalability and GSK volume
Drivers for the 15-20% annual revenue guidance
CEPI network reserve capacity and global role
Strategic reason for the Bioepis spin-off
Strategic impact of the HGS acquisition
Purpose of the Samsung Organoid business
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Samsung Biologics
- Record revenue growth and major contract wins set stage for continued expansion in 2025.207940
Q4 202425 Jun 2026 - Q2 revenue up 34% YoY, H1 revenue KRW 2.10T, strong CDMO and biosimilar growth.207940Q2 202423 Jun 2026
- Revenue for the first nine months of 2024 was ₩3.29T, with raised growth guidance and major deals.207940Q3 202423 Jun 2026
- Q1 2025 saw record revenue, robust CDMO margins, and major global expansion initiatives.207940Q1 202523 Jun 2026
- Q2 revenue up 11% YoY, H1 net income KRW 699.9B, guidance raised, spin-off underway.207940Q2 202523 Jun 2026
- Q3 2025 revenue up 40% YoY, operating profit up 115%, with robust growth and margin expansion.207940Q3 202523 Jun 2026
- 30% revenue growth in 2025, major contracts, and global expansion drive strong outlook.207940Q4 202521 Jan 2026
- Spin-off creates SEH to manage investments, enabling SBL and SBE to pursue focused growth.207940Investor Presentation6 Jun 2025
Next Samsung Biologics earnings date
Q2 202622 Jul, 2026
Samsung Biologics
Next Samsung Biologics earnings date
Q2 202622 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage